Latest Distribution Agreements News

Page 2 of 30
FBR has converted its first Mantis welding robot sale into a binding A$990,000 order and secured a North American distributor. The commercial progress comes alongside A$2.073 million of quarterly operating cash burn and a reported 0.12 quarters of funding at period end.
Victor Sage
Victor Sage
30 Oct 2026
EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.
Victor Sage
Victor Sage
30 Oct 2026
Me Today says more than 80% of its Series 1 warrants have been exercised, delivering $2.31 million of new capital as the nutraceuticals company forecasts stronger first-half FY27 revenue. FY26 gross revenue rose 36% to $7.96 million while the EBITDA loss narrowed substantially.
Victor Sage
Victor Sage
29 Oct 2026
Control Bionics has begun converting its expanded product and regulatory pipeline into revenue, while a completed $9.75 million capital raising gives the company a larger cash buffer. The next test is whether partner-led sales and NeuroStrip trial conversions can reduce its cash burn as planned.
Victor Sage
Victor Sage
29 Oct 2026
Skin Elements has converted its New Zealand Farmlands agreement into a first NZ$150,000 ECO-Nurture delivery, while A$900,000 in placement proceeds lifted quarter-end cash to A$1.455 million. The commercial progress comes alongside a cost review and a regulatory hurdle still standing between the company and broader national sales.
Ada Torres
Ada Torres
29 Oct 2026
Zimi has moved its next-generation Matter smart-home range closer to certification and production, while securing access to more than 10,000 retail outlets through Directed. But the company ended September with $344,000 in cash after burning $714,000 on operations, leaving further funding firmly in the frame.
Sophie Babbage
Sophie Babbage
28 Oct 2026
Sea Forest lifted first-quarter revenue 67% to A$3.4 million and generated a small operating cash inflow as it transitioned to a new distribution arrangement with Teys Australia. The agreement carries an indicative target of 480,000 cattle by June 2027, but the volume is not guaranteed and remains subject to implementation conditions.
Victor Sage
Victor Sage
28 Oct 2026
Veris is using its FY26 results and first-quarter trading update to make the case that its transformation from surveyor to digital and spatial advisory firm is gaining traction. Revenue and underlying EBITDA rose, while the planned Aurecon acquisition adds a near-term test of whether the strategy can convert into stronger earnings.
Victor Sage
Victor Sage
28 Oct 2026
icetana AI returned to revenue growth in FY26, with sales up 31% to $2.47 million and annual recurring revenue reaching $2.6 million. The company remains loss-making, but entered FY27 with stronger recurring revenue, new distribution channels and $4.79 million in cash.
Sophie Babbage
Sophie Babbage
27 Oct 2026
Wide Open Agriculture has extended Univar Solutions China’s exclusive distribution rights for its lupin protein products through 2028, preserving a route into the mainland Chinese market. But the agreement is not a purchase order: revenue depends first on WOA restoring commercial supply through contract manufacturing.
Victor Sage
Victor Sage
27 Oct 2026
Biome Australia has reported record pharmacy sell-through, further market-share gains and positive operating cash flow as it begins manufacturing Activated Probiotics domestically. The quarter also moved its China expansion and BMB18 clinical trial closer to key execution milestones.
Ada Torres
Ada Torres
26 Oct 2026
Proteomics International will take Promarker D and Promarker Eso nationwide through Healius from 26 October, extending its first commercial release beyond Western Australia and the Northern Territory. The tests will initially be offered privately at $495 and $997, while revenue remains too uncertain to forecast.
Victor Sage
Victor Sage
23 Oct 2026

Browse the archive

Full archive